Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PPP6R2P1 is a processed pseudogene in the human genome, derived from retrotransposition of the parental PPP6R2 gene sequence. It lacks coding potential for a functional protein due to features such as truncations, disabling mutations, or loss of regulatory elements. There is no evidence from reliable genomic databases or scientific literature that PPP6R2P1 encodes an active protein, directly participates in cellular signaling, or acts as a therapeutic target. Although emerging research has demonstrated that some pseudogenes can regulate the expression of their parental genes at the RNA level (e.g., via competing endogenous RNA mechanisms), there is currently no validated functional or disease-related role for PPP6R2P1 specifically[1]. In general, pseudogenes like PPP6R2P1 are not included in druggable target databases, and no interactions with approved drugs or implications for pharmacology have been described[1]. - PPP6R2P1 is not a protein-coding gene, not a receptor, enzyme, or known functional therapeutic target. - There is no evidence that it serves as a biomarker, nor are there safety or efficacy concerns relevant to drug development. - The gene is most accurately described as a pseudogene derived from the regulatory subunit 2 of protein phosphatase 6; it does not encode a protein, and should not be conflated with the functional PPP6R2 gene (Protein phosphatase 6 regulatory subunit 2)[1][3]. - Returning information for PPP6R2P1 is somewhat misleading if the intent was to describe a druggable target, so is_incorrect = true. Note: If you intended to refer to the functional regulatory subunit gene (PPP6R2, not PPP6R2P1), see details for "Protein phosphatase 6 regulatory subunit 2," which is distinct, protein-coding, and has established molecular function[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 6 regulatory subunit 2 pseudogene 1 (PPP6R2P1).